Back

Integrating genome and epigenome data to identify tissue-specific DNA methylation biomarkers for cancer risk

Yang, Y.; Chen, Y.; Xu, S.; Guo, X.; Jia, G.; Ping, J.; Shu, X.; Zhao, T.; Yuan, F.; Wang, G.; Xie, Y.; Ci, H.; Liu, D.; Ye, F.; Shu, X.-O.; Zheng, W.; Li, L.; Cai, Q.; Long, J.

2023-08-13 genetic and genomic medicine
10.1101/2023.08.09.23293899 medRxiv
Show abstract

The relationship between tissue-specific DNA methylation and cancer risk remains inadequately elucidated. Leveraging the Genotype-Tissue Expression (GTEx) consortium, we developed genetic models to predict DNA methylation at CpG sites (CpGs) across the genome for seven tissues and applied these models to genome-wide association study (GWAS) data of corresponding cancers, namely breast, colorectal, renal cell, lung, ovarian, prostate, and testicular germ cell cancers. At Bonferroni-corrected P<0.05, we identified 2,776 CpGs significantly associated with cancer risk, of which 92.7% (2,572) were specific to a particular cancer type. Notably, 57 CpGs within 35 putative novel loci retained significant associations with cancer risk after conditioning on proximal GWAS-identified signals. Further integrative multi-omics analyses revealed 791 CpG-gene-cancer trios, suggesting that DNA methylation at 248 distinct CpGs might influence cancer risk through regulating expression of 145 unique cis-genes. These findings substantially advance our understanding of the interplay between genetics, epigenetics, and gene expression in cancer etiology.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.